General Information of the Compound
| Compound ID |
CP0504203
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[2-[[1-[3-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]piperidin-4-yl]amino]ethyl]phenyl]acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H35N7O
|
||||||||||||||||||
| Molecular Weight |
485.636
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)Nc1ccc(CCNC2CCN(CCCc3c[nH]c4ccc(cc34)-n3cnnc3)CC2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H35N7O/c1-21(36)33-25-6-4-22(5-7-25)10-13-29-24-11-15-34(16-12-24)14-2-3-23-18-30-28-9-8-26(17-27(23)28)35-19-31-32-20-35/h4-9,17-20,24,29-30H,2-3,10-16H2,1H3,(H,33,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
VBZYBVZLUCGERA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01202, 5-hydroxytryptamine receptor 1B
Protein ID: PT00827, 5-hydroxytryptamine receptor 1D